Scagliotti GV, et al. Nintedanib + pemetrexed/cisplatin in patients with unresectable MPM: phase III results from the LUME-Meso trial. IASLC 2018, abstract PL02.09.
Gunstige langetermijnuitkomsten watch & wait-strategie bij rectumcarcinoom
aug 2018 | Maag-darm-leveroncologie